Barclays’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-164,104
| Closed | -$3.19M | – | 4598 |
|
|
2018
Q1 | $3.19M | Buy |
164,104
+49,748
| +44% | +$967K | ﹤0.01% | 1109 |
|
|
2017
Q4 | $1.91M | Buy |
114,356
+32,355
| +39% | +$539K | ﹤0.01% | 1281 |
|
|
2017
Q3 | $1.67M | Sell |
82,001
-5,979
| -7% | -$121K | ﹤0.01% | 1320 |
|
|
2017
Q2 | $1.42M | Buy |
87,980
+86,428
| +5,569% | +$1.39M | ﹤0.01% | 1381 |
|
|
2017
Q1 | $19K | Sell |
1,552
-10,047
| -87% | -$123K | ﹤0.01% | 3389 |
|
|
2016
Q4 | $154K | Buy |
11,599
+10,287
| +784% | +$137K | ﹤0.01% | 2421 |
|
|
2016
Q3 | $31K | Sell |
1,312
-99,335
| -99% | -$2.35M | ﹤0.01% | 2903 |
|
|
2016
Q2 | $2.9M | Buy |
100,647
+100,199
| +22,366% | +$2.89M | ﹤0.01% | 942 |
|
|
2016
Q1 | $14K | Sell |
448
-23,491
| -98% | -$734K | ﹤0.01% | 2870 |
|
|
2015
Q4 | $1.01M | Sell |
23,939
-17,154
| -42% | -$721K | ﹤0.01% | 1358 |
|
|
2015
Q3 | $1.44M | Buy |
41,093
+37,369
| +1,003% | +$1.31M | ﹤0.01% | 1245 |
|
|
2015
Q2 | $168K | Sell |
3,724
-6,351
| -63% | -$287K | ﹤0.01% | 2141 |
|
|
2015
Q1 | $463K | Sell |
10,075
-107,257
| -91% | -$4.93M | ﹤0.01% | 1964 |
|
|
2014
Q4 | $3.64M | Buy |
117,332
+59,512
| +103% | +$1.84M | ﹤0.01% | 1053 |
|
|
2014
Q3 | $1.33M | Buy |
57,820
+33,334
| +136% | +$767K | ﹤0.01% | 1548 |
|
|
2014
Q2 | $710K | Buy |
24,486
+10,026
| +69% | +$291K | ﹤0.01% | 1852 |
|
|
2014
Q1 | $376K | Buy |
14,460
+1,844
| +15% | +$47.9K | ﹤0.01% | 2093 |
|
|
2013
Q4 | $316K | Sell |
12,616
-25,099
| -67% | -$629K | ﹤0.01% | 2372 |
|
|
2013
Q3 | $755K | Sell |
37,715
-12,511
| -25% | -$250K | ﹤0.01% | 1868 |
|
|
2013
Q2 | $1M | Buy |
+50,226
| New | +$1M | ﹤0.01% | 1738 |
|